Yokohama, Japan

Ko Sakata


Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • Tokyo, JP (1979 - 1980)
  • Kawasaki, JP (1985 - 1987)
  • Yokohama, JP (1993 - 1994)

Company Filing History:


Years Active: 1979-1994

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ko Sakata

Introduction

Ko Sakata is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of podophyllotoxins and serum-free culture media. With a total of 8 patents to his name, Sakata's work has advanced the understanding and application of plant-based compounds in medical therapies.

Latest Patents

Sakata's latest patents include innovative processes for the production of podophyllotoxins using plants from the genus Podophyllum. One notable patent describes a method for preparing adventive embryos of Podophyllum, which involves incubating plant cells in a sugar-free medium followed by a medium with higher sugar content. Another patent outlines a process for generating podophyllotoxin compounds from adventive embryos and adventitious organs. Additionally, he has developed an agent for stimulating the growth of animal cells in vitro, which incorporates ginseng or its active ingredients. This serum-free culture media enhances lymphocyte growth and facilitates vital cell transplant therapy.

Career Highlights

Ko Sakata is currently associated with Nippon Oil Company, where he continues to innovate and contribute to the field of biotechnology. His work has not only advanced scientific knowledge but has also paved the way for practical applications in medicine and cell culture.

Collaborations

Sakata has collaborated with notable colleagues such as Hirosuke Imai and Masao Imaizumi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Ko Sakata's contributions to biotechnology through his patents and collaborative efforts have made a significant impact in the field. His innovative approaches to producing podophyllotoxins and developing serum-free media are paving the way for future advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…